APA

Ferster A., Corazza F., Vertongen F., Bujan W., Devalck C., Fondu P., Cochaux P., Lambermont M., Khaladji Z. & Sariban E. (19951018). Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. : British journal of haematology.

Chicago

Ferster A, Corazza F, Vertongen F, Bujan W, Devalck C, Fondu P, Cochaux P, Lambermont M, Khaladji Z and Sariban E. 19951018. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. : British journal of haematology.

Harvard

Ferster A., Corazza F., Vertongen F., Bujan W., Devalck C., Fondu P., Cochaux P., Lambermont M., Khaladji Z. and Sariban E. (19951018). Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. : British journal of haematology.

MLA

Ferster A, Corazza F, Vertongen F, Bujan W, Devalck C, Fondu P, Cochaux P, Lambermont M, Khaladji Z and Sariban E. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. : British journal of haematology. 19951018.